Trial Profile
A study evaluating the pharmacokinetics, safety, and tolerability of vortioxetine in young adults following single rising or multiple doses.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Oct 2017
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
- 13 Oct 2017 New trial record